Ignite Creation Date:
2025-12-24 @ 7:37 PM
Ignite Modification Date:
2026-02-01 @ 10:42 PM
Study NCT ID:
NCT01269203
Status:
WITHDRAWN
Last Update Posted:
2012-09-07
First Post:
2010-12-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy of NF-kB Inhibition for Reducing Symptoms During Maintenance Therapy in Multiple Myeloma Patients
Sponsor:
M.D. Anderson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Multiple Myeloma | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | multiple myeloma | View |
| None | MM | View |
| None | maintenance therapy | View |
| None | lenalidomide | View |
| None | bone marrow transplantation | View |
| None | auto-HSCT | View |
| None | Autologous Hematopoietic Stem Cell Transplantation | View |
| None | NF-kB inhibition | View |
| None | reducing symptoms | View |
| None | maintenance chemotherapy | View |
| None | inflammatory cytokines | View |
| None | nuclear factor kappa B | View |
| None | NF-kB | View |
| None | interleukin | View |
| None | IL-6 | View |
| None | tumor necrosis factor | View |
| None | TNF-a | View |
| None | NF-kB activation levels | View |